Annual EBITDA
Summary
- Current Value
- As of today, COR annual EBITDA is $4.98B, up +20.06% on
- Historical Performance
- COR annual EBITDA is up +44.50% over the past 3 years, and up +105.46% over the past 5 years
- All-Time High Comparison
- COR annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COR annual EBITDA is +45.80% above its 3-year low of $3.42B reached on
- Sector Comparison
- COR annual EBITDA is higher than 97.71% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.98B | +20.1% | +44.5% | +105.5% | +319.7% | |
| Quarterly EBITDA | $1.20B | +26.7% | +66.8% | +91.4% | +324.3% | |
| TTM EBITDA | $4.80B | +16.7% | +39.0% | +97.7% | +303.7% | |
| Price | $335.69 | +41.1% | +103.5% | +205.1% | +861.0% | |
| PE Ratio | 42.22 | +24.8% | +110.7% | – | +174.3% | |
| Annual Revenue | $321.33B | +9.3% | +34.7% | +69.2% | +312.2% | |
| Annual EPS | $7.96 | +5.7% | -1.0% | +147.8% | +258.6% | |
| Annual EBIT | $3.93B | +29.4% | +43.0% | +94.3% | +261.4% | |
| Annual Net Income | $1.57B | +3.2% | -5.9% | +146.1% | +146.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.98B | at high | |
| 5Y | $4.98B | at high | |
| All | $4.98B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.42B | +45.8% | |
| 5Y | $2.43B | N/A | +105.5% |
| All | $92.60M | +5283.0% |
EBITDA History
FAQ
What is the current annual EBITDA of COR?
As of today, COR annual EBITDA is $4.98B
What is 1-year change in COR annual EBITDA?
COR annual EBITDA is up +20.06% year-over-year
What is 3-year change in COR annual EBITDA?
COR annual EBITDA is up +44.50% over the past 3 years
How far is COR annual EBITDA from its all-time high?
COR annual EBITDA is currently at its all-time high
How does COR annual EBITDA rank versus sector peers?
COR annual EBITDA is higher than 97.71% of companies in Healthcare sector
When is COR next annual earnings release?
As of today, the next annual earnings release for COR has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, COR quarterly EBITDA is $1.20B, down -2.98% on
- Historical Performance
- COR quarterly EBITDA is up +26.68% year-over-year, and up +66.84% over the past 3 years
- All-Time High Comparison
- COR quarterly EBITDA is currently -5.69% below its historical high of $1.28B set on
- 3-Year Low Comparison
- COR quarterly EBITDA is +52.68% above its 3-year low of $789.04M reached on
- Sector Comparison
- COR quarterly EBITDA is higher than 97.29% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.20B | -3.0% | +26.7% | +66.8% | +91.4% | |
| Annual EBITDA | $4.98B | – | +20.1% | +44.5% | +105.5% | |
| TTM EBITDA | $4.80B | +5.6% | +16.7% | +39.0% | +97.7% | |
| Price | $335.69 | +6.9% | +41.1% | +103.5% | +205.1% | |
| PE Ratio | 42.22 | +6.9% | +24.8% | +110.7% | – | |
| Quarterly Revenue | $83.73B | +3.8% | +5.9% | +36.9% | +70.0% | |
| Quarterly EPS | -$1.75 | -149.8% | -10000.0% | -225.1% | +92.6% | |
| Quarterly EBIT | $945.94M | -4.0% | +40.6% | +71.5% | +79.2% | |
| Quarterly Net Income | -$333.07M | -148.3% | -4561.2% | -211.5% | +93.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.28B | -5.7% | |
| 3Y | $1.28B | -5.7% | |
| 5Y | $1.28B | -5.7% | |
| All | $1.28B | -5.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.07B | N/A | +12.5% |
| 3Y | $789.04M | +52.7% | |
| 5Y | $720.36M | N/A | +67.2% |
| All | $22.60M | +5230.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of COR?
As of today, COR quarterly EBITDA is $1.20B
What is COR quarterly EBITDA most recent change?
COR quarterly EBITDA was down -2.98% on September 30, 2025
What is 1-year change in COR quarterly EBITDA?
COR quarterly EBITDA is up +26.68% year-over-year
How far is COR quarterly EBITDA from its all-time high?
COR quarterly EBITDA is currently -5.69% below its historical high of $1.28B set on March 31, 2025
How does COR quarterly EBITDA rank versus sector peers?
COR quarterly EBITDA is higher than 97.29% of companies in Healthcare sector
When is COR next earnings release?
The next earnings release for COR is on
TTM EBITDA
Summary
- Current Value
- As of today, COR TTM EBITDA is $4.80B, up +5.59% on
- Historical Performance
- COR TTM EBITDA is up +16.73% year-over-year, and up +38.95% over the past 3 years
- All-Time High Comparison
- COR TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- COR TTM EBITDA is +45.00% above its 3-year low of $3.31B reached on
- Sector Comparison
- COR TTM EBITDA is higher than 97.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.80B | +5.6% | +16.7% | +39.0% | +97.7% | |
| Annual EBITDA | $4.98B | – | +20.1% | +44.5% | +105.5% | |
| Quarterly EBITDA | $1.20B | -3.0% | +26.7% | +66.8% | +91.4% | |
| Price | $335.69 | +6.9% | +41.1% | +103.5% | +205.1% | |
| PE Ratio | 42.22 | +6.9% | +24.8% | +110.7% | – | |
| TTM Revenue | $321.33B | +1.5% | +9.3% | +34.7% | +69.2% | |
| TTM EPS | $7.95 | -18.2% | +5.9% | -1.0% | +147.3% | |
| TTM EBIT | $3.74B | +7.9% | +24.8% | +35.8% | +84.7% | |
| TTM Net Income | $1.57B | -17.8% | +3.2% | -5.9% | +146.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.80B | at high | |
| 3Y | $4.80B | at high | |
| 5Y | $4.80B | at high | |
| All | $4.80B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.15B | N/A | +15.5% |
| 3Y | $3.31B | +45.0% | |
| 5Y | $2.61B | N/A | +83.9% |
| All | $24.40M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of COR?
As of today, COR TTM EBITDA is $4.80B
What is COR TTM EBITDA most recent change?
COR TTM EBITDA was up +5.59% on September 30, 2025
What is 1-year change in COR TTM EBITDA?
COR TTM EBITDA is up +16.73% year-over-year
How far is COR TTM EBITDA from its all-time high?
COR TTM EBITDA is currently at its all-time high
How does COR TTM EBITDA rank versus sector peers?
COR TTM EBITDA is higher than 97.56% of companies in Healthcare sector
When is COR next earnings release?
The next earnings release for COR is on
EBITDA Formula
Data Sources & References
- COR Official Website www.cencora.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1140859/000114085925000128/0001140859-25-000128-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1140859/000114085925000128/0001140859-25-000128-index.htm
- COR Profile on Yahoo Finance finance.yahoo.com/quote/COR
- COR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cor
